{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:30Z","timestamp":1772166690190,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006614","name":"Utah Department of Health","doi-asserted-by":"publisher","award":["236204"],"award-info":[{"award-number":["236204"]}],"id":[{"id":"10.13039\/100006614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medical Cannabis (MC) is authorized in numerous state-legislated programs to treat approved medical conditions. Notwithstanding MC access, some participants continue to use cannabis purchased outside of a state licensed MC pharmacy, otherwise known as illicit medicinal cannabis (IMC), to treat their medical conditions. Identifying barriers and contributors to MC use and motives for IMC use can promote safety, improve program design, and inform future research efforts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This exploratory analysis utilized baseline survey data from a convenience sample-based prospective cohort evaluation of newly registered (&lt;\u20096 months) adult participants in Utah\u2019s MC program who had been diagnosed with chronic pain, post-traumatic stress disorder, and\/or cancer. Participants completed surveys assessing physical and mental health, program experience, and barriers and contributors to MC access. We employed descriptive analysis, chi-squared analysis, and logistic regression to identify factors influencing IMC use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 273 MC program participants screened for eligibility, 227 were enrolled in the cohort evaluation, and 211 participants completed the baseline survey. Approximately 1 in 10 survey respondents (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200924, 11.9%) reported IMC use within the past two weeks. Participants accessing IMC were 40.5 years old, 58.3% male, 70.8% employed, and 87.5% white. Participants using IMC reported barriers to MC, including product cost (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919, 79%) and assurance of adequate supply (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911, 45.8%) as the most common motives for IMC use. Participants who reported experiencing MC access barriers were significantly more likely to report IMC use than those reporting no barriers (Odds Ratio (OR)\u2009=\u20094.73,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;.001). Participants using IMC reported lower levels of trust in (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;.04) and reliance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;.02) upon the state program and less reliance on MC pharmacists (p\u2019s\u2009&lt;\u20090.01). However, participants who relied on the state program for MC information were less likely to report IMC use (Adjusted Odds Ratio AOR\u2009=\u20090.16,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a state MC program, barriers related to MC access and cost indicated a significant increase in the likelihood of IMC use, while reliance on the state program for MC information indicated a significant decrease in the likelihood of IMC use. Future research can explore how increasing affordable access to MC and availability of reliable information may affect IMC use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-025-00284-w","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T11:17:18Z","timestamp":1752837438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding motives for illicit medicinal cannabis use: an exploratory analysis in a medical cannabis program"],"prefix":"10.1186","volume":"7","author":[{"given":"Carter","family":"Reeves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirit","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Taylor","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Incze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziji","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden","family":"Flake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"284_CR1","doi-asserted-by":"publisher","unstructured":"Rhee TG, Rosenheck RA. Increasing Use of Cannabis for Medical Purposes, Among US, Residents, American Journal of Preventive Medicine. 2013\u20132020. Vol. 65,. Elsevier BV; 2023. pp. 528\u201333. Available from: https:\/\/doi.org\/10.1016\/j.amepre.2023.03.005","DOI":"10.1016\/j.amepre.2023.03.005"},{"key":"284_CR2","unstructured":"Substance Abuse and Mental Health Services Administration. 2023 Companion infographic report: Results from the 2021, 2022, and 2023 National Surveys on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2024. Report No.: PEP24-07-020. Available from: https:\/\/www.samhsa.gov\/data\/report\/2021-2022-2023-nsduh-infographic"},{"key":"284_CR3","doi-asserted-by":"publisher","unstructured":"Hrdinova J. Ohio Medical Marijuana Control Program at Four Years: Evaluating Satisfaction and Perception. SSRN Electronic Journal. Elsevier BV; 2022. Available from: https:\/\/doi.org\/10.2139\/ssrn.4231400","DOI":"10.2139\/ssrn.4231400"},{"key":"284_CR4","doi-asserted-by":"publisher","unstructured":"Farrelly KN, Wardell JD, Marsden E, Scarfe ML, Najdzionek P, Turna J et al. The Impact of Recreational Cannabis Legalization on Cannabis Use and Associated Outcomes: A Systematic Review. Vol. 17, Substance Abuse: Research and Treatment. SAGE Publications; 2023. p. 117822182311720. Available from: https:\/\/doi.org\/10.1177\/11782218231172054","DOI":"10.1177\/11782218231172054"},{"key":"284_CR5","doi-asserted-by":"publisher","unstructured":"Mahamad S, Wadsworth E, Rynard V, Goodman S, Hammond D. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation. Vol. 39, Drug and Alcohol Review. Wiley; 2020. pp. 337\u201346. Available from: https:\/\/doi.org\/10.1111\/dar.13069","DOI":"10.1111\/dar.13069"},{"key":"284_CR6","doi-asserted-by":"publisher","unstructured":"Jameson LE, Conrow KD, Pinkhasova DV, Boulanger HL, Ha H, Jourabchian N et al. Comparison of State-Level Regulations for Cannabis Contaminants and Implications for Public Health. Vol. 130, Environmental Health Perspectives. Environmental Health Perspectives; 2022. Available from: https:\/\/doi.org\/10.1289\/EHP11206","DOI":"10.1289\/EHP11206"},{"key":"284_CR7","doi-asserted-by":"publisher","unstructured":"Sevigny EL, Pacula RL, Heaton P. The effects of medical marijuana laws on potency. Vol. 25, International Journal of Drug Policy. Elsevier BV; 2014. pp. 308\u201319. Available from: https:\/\/doi.org\/10.1016\/j.drugpo.2014.01.003","DOI":"10.1016\/j.drugpo.2014.01.003"},{"key":"284_CR8","doi-asserted-by":"publisher","unstructured":"Matsuzaki M, Vu QM, Gwadz M, Delaney JAC, Kuo I, Trejo MEP et al. Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR). Vol. 18, BMC Public Health. Springer Science and Business Media LLC; 2018. Available from: https:\/\/doi.org\/10.1186\/s12889-018-5291-2","DOI":"10.1186\/s12889-018-5291-2"},{"key":"284_CR9","doi-asserted-by":"publisher","unstructured":"Moallef S, Homayra F, Milloy MJ, Bird L, Nosyk B, Hayashi K. High Prevalence of Unmet Healthcare Need among People who use Illicit Drugs in a Canadian Setting with Publicly-Funded Interdisciplinary Primary Care Clinics. Vol. 42, Substance Abuse. SAGE Publications; 2021. pp. 760\u20136. Available from: https:\/\/doi.org\/10.1080\/08897077.2020.1846667","DOI":"10.1080\/08897077.2020.1846667"},{"key":"284_CR10","doi-asserted-by":"publisher","unstructured":"King C, Collins D, Patten A, Nicolaidis C, Englander H. Trust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study. Vol. 16, Journal of Addiction Medicine. Ovid Technologies (Wolters Kluwer Health); 2021. pp. 41\u20138. Available from: https:\/\/doi.org\/10.1097\/ADM.0000000000000819","DOI":"10.1097\/ADM.0000000000000819"},{"key":"284_CR11","doi-asserted-by":"publisher","unstructured":"Thom DH, Hall MA, Pawlson LG. Measuring Patients\u2019 Trust In Physicians When Assessing Quality Of Care. Vol. 23, Health Affairs. Health Affairs (Project Hope); 2004. pp. 124\u201332. Available from: https:\/\/doi.org\/10.1377\/hlthaff.23.4.124","DOI":"10.1377\/hlthaff.23.4.124"},{"key":"284_CR12","doi-asserted-by":"publisher","unstructured":"Shonesy BC, Williams D, Simmons D, Dorval E, Gitlow S, Gustin RM, Screening. Brief Intervention, and Referral to Treatment in a Retail Pharmacy Setting: The Pharmacist\u2019s Role in Identifying and Addressing Risk of Substance Use Disorder. Vol. 13, Journal of Addiction Medicine. Ovid Technologies (Wolters Kluwer Health); 2019. pp. 403\u20137. Available from: https:\/\/doi.org\/10.1097\/ADM.0000000000000525","DOI":"10.1097\/ADM.0000000000000525"},{"key":"284_CR13","doi-asserted-by":"publisher","unstructured":"Donnan J, Shogan O, Bishop L, Swab M, Najafizada M. Characteristics that influence purchase choice for cannabis products: a systematic review. Vol. 4, Journal of Cannabis Research. Springer Science and Business, Media LLC. 2022. Available from: https:\/\/doi.org\/10.1186\/s42238-022-00117-0","DOI":"10.1186\/s42238-022-00117-0"},{"key":"284_CR14","doi-asserted-by":"publisher","unstructured":"Lintzeris N, Mills L, Abelev SV, Suraev A, Arnold JC, McGregor IS. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20). Vol. 19, Harm Reduction Journal. Springer Science and Business, Media LLC. 2022. Available from: https:\/\/doi.org\/10.1186\/s12954-022-00666-w","DOI":"10.1186\/s12954-022-00666-w"},{"key":"284_CR15","doi-asserted-by":"publisher","unstructured":"Lintzeris N, Mills L, Suraev A, Bravo M, Arkell T, Arnold JC et al. Medical cannabis use in the Australian community following introduction of legal access: the 2018\u20132019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18). Vol. 17, Harm Reduction Journal. Springer Science and Business Media LLC; 2020. Available from: https:\/\/doi.org\/10.1186\/s12954-020-00377-0","DOI":"10.1186\/s12954-020-00377-0"},{"key":"284_CR16","unstructured":"Minnesota Department of Health: Office of Medical Cannabis. Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year. Minnesota Legislative Reference Library. p. 173. 2016. https:\/\/www.health.state.mn.us\/people\/cannabis\/docs\/about\/firstyearreport.pdf"},{"key":"284_CR17","unstructured":"Sofis M, Slade LM, Boyum M. H. Examination of experiences, behaviors, and outcomes of medical Cannabis patients and providers in new Mexico. Cannabis public policy consulting the state of new Mexico department of health. p. 11\/22\/2022. 2022. https:\/\/www.nmhealth.org\/publication\/view\/report\/7954\/"},{"key":"284_CR18","unstructured":"Cannabis Public Policy Consulting. Maryland Medical Cannabis Patient Survey Report. Maryland Medical Cannabis Commission. 2022. https:\/\/cannabis.maryland.gov\/Documents\/2024%20Reports\/MMCPS-22-Addendum-V5.pdf"},{"key":"284_CR19","doi-asserted-by":"publisher","unstructured":"Amlung M, Reed DD, Morris V, Aston ER, Metrik J, MacKillop J. Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis. Vol. 114, Addiction. Wiley; 2018. pp. 112\u20138. Available from: https:\/\/doi.org\/10.1111\/add.14437","DOI":"10.1111\/add.14437"},{"key":"284_CR20","doi-asserted-by":"publisher","unstructured":"Stall NM, Shi S, Malikov K, Wang S, Rochon PA, Hillmer MP, JAMA Internal Medicine. Edible Cannabis Legalization and Cannabis Poisonings in Older Adults. Vol. 184,. American Medical Association (AMA); 2024. p. 840. Available from: https:\/\/doi.org\/10.1001\/jamainternmed.2024.1331","DOI":"10.1001\/jamainternmed.2024.1331"},{"key":"284_CR21","doi-asserted-by":"publisher","unstructured":"Croker JA, Werts M, Couch ET, Chaffee BW. Cannabis use among adolescents and emerging adults who use e-cigarettes: Findings from an online, national U.S. Sample. Vol. 140, Addictive Behaviors. Elsevier BV; 2023. p. 107620. Available from: https:\/\/doi.org\/10.1016\/j.addbeh.2023.107620","DOI":"10.1016\/j.addbeh.2023.107620"},{"key":"284_CR22","doi-asserted-by":"publisher","unstructured":"Robertson K, Thyne M. Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source. Vol. 24, Preventive Medicine Reports. Elsevier BV; 2021. p. 101639. Available from: https:\/\/doi.org\/10.1016\/j.pmedr.2021.101639","DOI":"10.1016\/j.pmedr.2021.101639"},{"key":"284_CR23","doi-asserted-by":"publisher","unstructured":"Khademi S, Hallinan CM, Conway M, Bonomo Y. Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review. Vol. 25, Journal of Medical Internet Research. JMIR Publications Inc.; 2023. p. e36667. Available from: https:\/\/doi.org\/10.2196\/36667","DOI":"10.2196\/36667"},{"key":"284_CR24","doi-asserted-by":"publisher","unstructured":"Matthews S, Dwyer R, Snoek A, Stigma. and Self-Stigma in Addiction [Internet]. Vol. 14, Journal of Bioethical Inquiry. Springer Science and Business Media LLC; 2017. pp. 275\u201386. Available from: https:\/\/doi.org\/10.1007\/s11673-017-9784-y","DOI":"10.1007\/s11673-017-9784-y"},{"key":"284_CR25","doi-asserted-by":"publisher","unstructured":"Erridge S, Troup L, Sodergren MH. Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study [Internet]. Vol. 10, JMIR Public Health and Surveillance. JMIR Publications Inc.; 2024. pp. e57595\u2013e57595. Available from: https:\/\/doi.org\/10.2196\/57595","DOI":"10.2196\/57595"},{"key":"284_CR26","doi-asserted-by":"publisher","unstructured":"Fong C, Mateu-Gelabert P, Ciervo C, Eckhardt B, Aponte-Melendez Y, Kapadia S et al. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Vol. 221, Drug and Alcohol Dependence. Elsevier BV; 2021. p. 108589. Available from: https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108589","DOI":"10.1016\/j.drugalcdep.2021.108589"},{"key":"284_CR27","doi-asserted-by":"publisher","unstructured":"Weng HC. Does the physician\u2019s emotional intelligence matter? Vol. 33, Health Care Management Review. Ovid Technologies (Wolters Kluwer Health); 2008. pp. 280\u20138. Available from: https:\/\/doi.org\/10.1097\/01.HCM.0000318765.52148.b3","DOI":"10.1097\/01.HCM.0000318765.52148.b3"},{"key":"284_CR28","doi-asserted-by":"publisher","unstructured":"Boehnke KF, Smith T, Elliott MR, Wilson-Poe AR, Kruger DJ. Cannabis-related information sources among US residents: A probability-weighted nationally representative survey. Vol. 6, Journal of Cannabis Research. Springer Science and Business, Media LLC. 2024. Available from: https:\/\/doi.org\/10.1186\/s42238-024-00249-5","DOI":"10.1186\/s42238-024-00249-5"},{"key":"284_CR29","doi-asserted-by":"publisher","unstructured":"The Health Effects of Cannabis and Cannabinoids. National Academies Press. 2017. Available from: https:\/\/doi.org\/10.17226\/24625","DOI":"10.17226\/24625"},{"key":"284_CR30","doi-asserted-by":"publisher","unstructured":"Sarma A, Pu X, Chi Y, Brown ET, Correll M, Kay M. Odds and insights: decision quality in exploratory data analysis under uncertainty. In: Proceedings of the 2024 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery; 2024. Available from: https:\/\/doi.org\/10.1145\/3613904.3641995","DOI":"10.1145\/3613904.3641995"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00284-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T11:17:22Z","timestamp":1752837442000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-025-00284-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00284-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5596197\/v1","asserted-by":"object"}]},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Utah IRB approved all evaluation procedures for protocol #164305. Informed and written consent was gathered from all participants from evaluation staff.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}